NFE2L2 and osteosarcoma: Further proof of ferroptosis induction by impairing STAT3/NRF2/GPX4 signaling is observed in osteosarcoma cells, where STAT3 inhibitors reactivated ferroptosis and increased cisplatin sensitivity [82].